ScienceDex / Researcher record
Pal, Ranajit
- Advanced Bioscience Laboratories, Inc. (no department on record)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Sustained Excellence
- Long-Funded
NIH Funding · FY2018
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2011 | $627,681 | 1 | #12,263 |
| 2012 | $931,497 | 1 | #7,652 |
| 2013 | $662,121 | 1 | #10,848 |
| 2014 | $4,856,154 | 9 | #678 |
| 2015 | $5,311,559 | 10 | #594 |
| 2016 | $7,592,997 | 10 | #266 |
| 2017 | $7,338,532 | 9 | #237 |
| 2018 | $10,329,576 | 13 | #144 |
| 2019 | $5,444,071 | 9 | #562 |
| 2022 | $113,273 | 2 | #43,146 |
| 2023 | $41,060 | 3 | #48,104 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20111 record
- FY20121 record
- FY20131 record
- FY20149 records
- FY201510 records
- FY201610 records
- FY20179 records
- FY2018 · selected13 records
- FY20199 records
- FY20222 records
- FY20233 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award records by amount
NIH award records listing Pal, Ranajit as a PI. Multi-PI records show the full award amount for context.
- 272201300002I-8-27200004-1N01Contact PISVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY$2.3Maward amount
- 272201300002I-0-27200018-1N01Contact PIEVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES$2Maward amount
- 272201300002I-0-27200019-1N01Contact PIEvaluation of the Immunogenicity and Efficacy of a MVA-HIV Prime, gp145 HIV protein/ALFA-adjuvanted Boost Vaccine Regimen with SHIV-CH505 Challenge in Male Rhesus Macaques$941.1Kaward amount
- 272201600008I-0-27200013-1N01Contact PIPRECLINICAL GAP-FILLING SERVICES: STUDIES TO ASSESS INTERACTIONS BETWEEN DAPIVIRINE AND VAGINALLY-APPLIED, OVER-THE-COUNTER PRODUCTS$919.2Kaward amount
- 272201600008I-1-27200007-1N01Contact PINONHUMAN PRIMATE PURCHASE AND HOLDING$897.8Kaward amount
- 272201600008I-2-27200001-1N01Contact PIComprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)$790.6Kaward amount
- 272201600008I-0-27200014-1N01Contact PICHARACTERIZATION OF THE PHARMACOKINETIC PROFILE OF A CANDIDATE HIV PREVENTION DRUG IN RHESUS MACAQUES$758.1Kaward amount
- 272201600008I-1-27200011-1N01Contact PIStatistical Support for HIV Non-vaccine Biomedical Prevention Product Development$406.9Kaward amount
- 272201600008I-0-27200012-1N01Contact PIEXPANSION AND CHARACTERIZATION OF RELEVANT SIMIAN IMMUNODEFICIENCY VIRUS (SIV) STOCKS FOR USE IN DRUG ASSAYS OR REPEAT, LOW-DOSE CHALLENGE STUDIES IN RHESUS MACAQUES$359.9Kaward amount
- 272201300002I-1-27200015-1N01Contact PISIMIAN VACCINE EVALUATION UNITS: Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy$355.4Kaward amount
+3 more grants not shown.
Award organization
Organizations that administered FY2018 awards listing Pal, Ranajit as a PI.
FY2018 award administered by Advanced Bioscience Laboratories, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardAdvanced Bioscience Laboratories, Inc.
- 2011$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012Entered Top 50% NationallyRanked #7652
- 2013$2M Cumulative Funding
- 2014$5M Cumulative Funding
- 2014Entered Top 25% NationallyRanked #678
- 2014Entered Top 10% NationallyRanked #678
- 2014Entered Top 5% NationallyRanked #678
- 2015$10M Cumulative Funding
- 2017$25M Cumulative Funding
- 2018Entered Top 1% NationallyRanked #144